Ventyx Biosciences’ (VTYX) Outperform Rating Reiterated at Oppenheimer
Oppenheimer reissued their outperform rating on shares of Ventyx Biosciences (NASDAQ:VTYX – Free Report) in a research report report published on Friday morning,Benzinga reports. The firm currently has a $9.00 target price on the stock, down from their prior target price of $10.00. VTYX has been the subject of several other reports. Wells Fargo & […]
More Stories
Runway Growth Finance Corp. (NASDAQ:RWAY) Short Interest Down 17.5% in October
Runway Growth Finance Corp. (NASDAQ:RWAY – Get Free Report) was the recipient of a significant drop in short interest in...
Minerva S.A. (OTCMKTS:MRVSY) Short Interest Update
Minerva S.A. (OTCMKTS:MRVSY – Get Free Report) saw a significant drop in short interest in the month of October. As...
Short Interest in Publicis Groupe S.A. (OTCMKTS:PUBGY) Declines By 17.8%
Publicis Groupe S.A. (OTCMKTS:PUBGY – Get Free Report) was the recipient of a large decrease in short interest during the...
Southwest Airlines Plane Hit by Gunfire Before Takeoff at Dallas Airport
By Aldgra Fredly A Southwest Airlines plane was hit by gunfire while preparing for takeoff at Dallas Love Field airport...
Hidden Risks in Refined Wheat Flour: Tips on How to Eat for Better Health
By Jingduan Yang, M.D. Health Viewpoints Many foods are made from refined wheat, and although they are a popular dietary...
Evergreen Co. (NASDAQ:EVGR) Short Interest Update
Evergreen Co. (NASDAQ:EVGR – Get Free Report) saw a significant growth in short interest in October. As of October 31st,...